A Closer Look at 5 Analyst Recommendations For Stoke Therapeutics

BenzingaJun 29 00:01

Needham Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $22

Needham analyst Joseph Stringer maintains $Stoke Therapeutics(STOK.US)$ with a buy rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success rate of 39.9% and

Futu NewsJun 28 18:33 · Ratings

Needham Reiterates Buy on Stoke Therapeutics, Maintains $22 Price Target

BenzingaJun 28 18:12

Stoke Therapeutics Analyst Ratings

BenzingaJun 28 18:10

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

BenzingaJun 24 15:32

Stoke Therapeutics Announces Chief Operating Officer Huw Nash To Step Down, Will Continue As Chief Business Officer Effective June 18, 2024

BenzingaJun 22 04:09